title: Beta-blocker therapy induces ventricular resynchronization in dilated cardiomyopathy with narrow QRS complex.
abstract: OBJECTIVE
  We sought to evaluate the effects of beta-blocker therapy on regional and global myocardial mechanics in addition to ventricular synchrony in patients with heart failure and normal QRS by using tissue Doppler and strain echocardiography.
  
  
  BACKGROUND
  It is unknown whether beta-blocker therapy can influence mechanical synchrony.
  
  
  METHODS
  Conventional and strain echocardiography were performed in 15 healthy age-matched volunteers and in 25 patients with idiopathic dilated cardiomyopathy (IDC). Of these, 15 IDC patients on standard heart failure therapy were studied prior to and at 1 and 6 months after initiation of carvedilol therapy and compared to the controls.
  
  
  RESULTS
  There was significant mechanical dyssynchrony in IDC compared with control patients. Patients placed on carvedilol demonstrated a significant decrease in the inferoseptal to lateral wall delay in peak strain (normalized to the R-R interval) between baseline and 1 month and between baseline and 6 months. Similarly, global time to peak segmental strain (455 +/- 51 ms vs. 423 +/- 59 ms, respectively, p = 0.02, and 455 +/- 51 ms vs. 415 +/- 50 ms, respectively, p = 0.01) and the coefficient of variation of the time to peak segmental strain decreased (17 +/- 4% vs. 15 +/- 5%, respectively, p = 0.02, and 17 +/- 4% vs. 14 +/- 5%, respectively, p = 0.03), from baseline to 1 month and between baseline and 6 months, respectively. Global strain significantly increased from baseline to 1 month (-8.2 +/- 1.8 to -10.4 +/- 3.9, respectively, p = 0.01) and between baseline and 6 months (-8.2 +/- 1.8% to -12.0 +/- 3.2%, respectively, p = 0.008). Improvements in left ventricular ejection fraction and reverse remodeling were coincident with reductions in mechanical dyssynchrony.
  
  
  CONCLUSIONS
  The use of carvedilol improves contractile function and dyssynchrony in heart failure patients with normal QRS.
authors.affiliation: Department of Internal Medicine and Cardiology, Osaka City University School of Medicine, Osaka, Japan. yatakemoto@med.osaka-cu.ac.jp
authors.forename: Yasuhiko
authors.initials: Y
authors.lastname: Takemoto
authors.forename: Takeshi
authors.initials: T
authors.lastname: Hozumi
authors.forename: Kenichi
authors.initials: K
authors.lastname: Sugioka
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Takagi
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Matsumura
authors.forename: Minoru
authors.initials: M
authors.lastname: Yoshiyama
authors.forename: Theodore P
authors.initials: TP
authors.lastname: Abraham
authors.forename: Junichi
authors.initials: J
authors.lastname: Yoshikawa
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002227:Carbazoles / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000175:diagnosis / Q000188:drug therapy*; D000077261:Carvedilol; D015150:Echocardiography, Doppler; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000627:therapeutic use; D012016:Reference Values; D016276:Ventricular Function / Q000187:drug effects*
chemical_list: D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol